Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan sequential to Carboplatin/Paclitaxel in ovarian cancer
NCT00102375Phase 3Completed
- Sponsor
- AGO Study Group
- Start
- Dec 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topotecan in ovarian cancer, sponsored by AGO Study Group. Started Dec 1999; status: completed.
02
Drugs
topotecan
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00102375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102375.